The latest Houston cohort for gBETA has been announced. Photo courtesy of gBETA

The sixth Houston cohort for global startup accelerator and investor gener8tor's gBETA program is underway, and five Houston early-stage companies have joined the program.

The no-equity program, which is based out of the Downtown Launchpad, kicked off in September and lasts seven weeks. In that time, the startups are connected to a national network of mentors, customers, corporate partners, and investors.

“This gener8tor Houston cohort is among our strongest yet,” says Robert Pieroni, director of Economic Development at Central Houston Inc., in the news release. “We are excited about the caliber of entrepreneurs the Downtown Launchpad is attracting and the entrepreneurial ecosystem being created.”

The program concludes at a public showcase event at 5 pm on November 17 at Amegy Bank Courtyard.

“I’m thrilled about this cohort,” says Muriel Foster, gBETA Houston director, in the release. “We’ve seen the incredible economic impact of the gBETA program in other parts of the country, and we’re excited to bring that same impact to Houston.”

Here are the members of gBETA Houston's latest cohort:

CultureLancer

CultureLancer's all-in-one career-focused platform connects students at HBCUs with opportunities to gain industry-specific education and experience. CultureLancer also provides companies with the ability to source qualified diverse talent to meet their needs. CultureLancer has onboarded 30 students with each completing certification in digital marketing, closing on two contracts, and currently onboarding companies for beta testing.

EYF

EYF gamifies financial literacy education and provides children with a fun alternative to educational programming. EYF aims to teach financial literacy and economics in a fun, interactive, and applicable way. EYF is set to go to market at the end of of the year.

Oodles

Oodles automates the sales process and 24/7 customer service for e-commerce retailers through a conversational AI chatbot. Leveraging AI and machine learning, Oodles chatbot results in significant cost savings for retailers and improves customer retention and loyalty. Oodles has currently raised a seed round of $280,000, launched the product, and onboarded 10 customers.

SafetyKay

SafetyKay LLC promotes safety awareness to young children. SafetyKay focuses on decreasing fatality and accident rates among children ages 5-12 years by teaching them critical health and safety skills. SafetyKay's current safety awareness material has been viewed 81,359 times and it is currently in the process of transitioning into a mobile app platform.

Stobridge Education Inc.

Stobridge Education Inc. connects students with mentors and postsecondary education college, career and life resources for better outcomes. Through its comprehensive and fully integrated web and mobile platform, Stobridge Education is a safer alternative to LinkedIn for high school students. Stobridge Education has engaged with over 1,000 participants through their nonprofit partner, Adeiur and has implemented its module curriculum in two universities and four student-serving organizations.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

European spacecraft developer expands to Houston with U.S. business, new lab

houston hq

European aerospace manufacturer The Exploration Company has established its first U.S. entity and named Space City as its headquarters.

The company announced earlier this month that it has launched TEC Federal to support U.S. government customers and agencies, and to scale The Exploration Company's engineering operations in the country.

Mark Kirasich serves as president of TEC Federal. Kirasich most recently served as the senior director of human spaceflight at Blue Origin after a nearly 40-year career at NASA.

The Exploration Company is developing the reusable Nyx space vehicle. Nyx is designed to take off from any heavy launcher in the world. It will then dock at space stations, retrieve up to 3,000 kilograms of cargo, splash down and return the cargo to Earth. The company aims to make Nyx fully reusable for up to 10 missions, making it a more affordable and sustainable option for aerospace missions.

The Exploration Company completed a successful drop test of the spacecraft in May in the Mojave Desert. The company says Nyx is slated to perform its first flight demonstration in 2028.

In addition to launching the Houston business, The Exploration Company also opened its new Rapid Innovation Lab near Houston's NASA Johnson Space Center on Space Park Drive.

The Exploration Company opened its Rapid Innovation Lab earlier this month. Photo via LinkedIn

The Rapid Innovation Lab features a full-scale mockup of the future Nyx crew capsule as well as ongoing development and testing of the Nyx cargo capsule, according to the company.

The Exploration Company says the new lab will allow its engineers, designers, and operators to prototype and test crew interfaces. It will also support partnerships with NASA personnel and astronauts.

“Houston gives us direct access to the people and expertise that have built and operated human spaceflight systems for decades. We’re excited to invest and expand around that— engineers, operators, and astronauts working together and moving quickly towards building a crew capsule.” Hélène Huby, founder and CEO of The Exploration Company, said in a blog post.

According to The Houston Chronicle, The Exploration Company has about 30 employees in the Houston area.

The company was founded in 2021 by Huby, a French rocket scientist, and has raised more than $350 million in venture capital. It operates out of Germany, France, Luxembourg, Spain and Italy, with offices in the U.S. and the United Arab Emirates. It is also developing a reusable, high-thrust rocket engine known as Storm.

UH lands $4M NIH grant to study early signs of autoimmune disease

NIH funding

The University of Houston recently received a $4 million National Institutes of Health grant to support a 10-year longitudinal study to identify the earliest biological markers of autoimmune disease.

Led by Chandra Mohan, the Hugh Roy and Lillie Cranz Cullen Endowed Professor of Biomedical Engineering, the study aims to examine what causes Systemic Autoimmune Rheumatic Diseases (SARDs) and to identify targets for future treatments. The study will be carried out in collaboration with Dr. Karen Costenbader at Harvard Medical School, Boston.

SARDs include conditions like rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome and systemic sclerosis—all are considered chronic diseases currently without a cure. Autoimmune diseases affect over 30 million people globally, according to UH.

SARDs occur when the body’s immune system attacks healthy, non-threatening tissues and organs. According to UH, in these diseases, the body often attacks nuclear antigens, creating anti-nuclear autoantibodies, which can be early detection signs for SARDs in more than 50 percent of patients, Mohan says.

Researchers will study blood samples and environmental exposure over the 10 years to better understand anti-nuclear autoantibodies.

“Collectively, these studies will help identify the genetic, environmental and cellular factors that are operative at the two steps of SARD development, namely the emergence of anti-nuclear autoantibodies and disease onset,” Mohan said in a news release. “ More importantly, these studies will highlight functional molecular pathways and mechanisms that may be operative at each step."

Mohan predicts that looking at SARDs’ shared characteristics, rather than each disease individually, could help identify more treatment methods.

“Individual SARDs have been examined in silos without an attempt to discern shared underlying features at the molecular level,” he added in the release. “Current understanding of the initial (and likely shared) origins of SARDs is only rudimentary but urgently needed to develop means for prevention and treatment.”

Earlier this year, UH also received an $11 million NIH grant to conduct a first-of-its-kind study of early language development in children ages 18 to 24 months. Read more here.